Trials / Enrolling By Invitation
Enrolling By InvitationNCT06100510
PFA 100 Evaluation and Reference Interval HOACNY
- Status
- Enrolling By Invitation
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Hematology Oncology Associates of Central New York · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this research is to evaluate instrument functionality and develop a reference range of normal data by healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Aspirin 325mg | Cohort B will receive one (1) 325 mg aspirin 24 hours prior to their second blood draw. |
Timeline
- Start date
- 2024-02-19
- Primary completion
- 2024-10-10
- Completion
- 2024-10-10
- First posted
- 2023-10-25
- Last updated
- 2024-10-03
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06100510. Inclusion in this directory is not an endorsement.